# Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation

Study · id `cardio:ct-nct05145283` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05145283](<https://clinicaltrials.gov/study/NCT05145283>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05145283

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Valve and congenital heart disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 141 participants.

## Technical summary

Registry record NCT05145283. Randomized; double masking; primary purpose prevention. Start 2022-03-16 (actual); primary completion 2026-01-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 2
- Enrolled: 141 participants (enrolled count; ClinicalTrials.gov record NCT05145283, source copy `cardio:ctgov-nct05145283-2026-04-22`, retrieved 2026-10-26)
- Started: 2022-03-16 (actual) (ClinicalTrials.gov record NCT05145283, source copy `cardio:ctgov-nct05145283-2026-04-22`, retrieved 2026-10-26)
- Primary completion: 2026-01-05 (actual) (ClinicalTrials.gov record NCT05145283, source copy `cardio:ctgov-nct05145283-2026-04-22`, retrieved 2026-10-26)
- Completion: 2026-01-05 (actual) (ClinicalTrials.gov record NCT05145283, source copy `cardio:ctgov-nct05145283-2026-04-22`, retrieved 2026-10-26)
- Countries: Switzerland (ClinicalTrials.gov record NCT05145283, source copy `cardio:ctgov-nct05145283-2026-04-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05145283-2026-04-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation
- Acronym: PAIR-TAVI
- Condition: Acute Ischemic Stroke
- Condition: Acute Renal Injury
- Intervention (Drug): Conestat alfa (Ruconest®)
- Intervention (Drug): NaCl 0.9%)
- Lead sponsor: University Hospital, Basel, Switzerland
- Lead sponsor class: OTHER
- Collaborator: Swiss National Science Foundation
- Collaborator class: OTHER
- Collaborator: Pharming Technologies B.V.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: University Hospital, Basel, Switzerland (`cardio:org-university-hospital-basel-switzerland`)
- Registry lists this organization as a collaborator: Swiss National Science Foundation (`cardio:org-swiss-national-science-foundation`)

## Provenance

Content hash: 232155fd2da040e326dcb258218c38640159d709229a682479e7fe6e048e2eaf
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
